OUR WORK

The APG faculty's portfolio of research activity is robust and highly productive. Research efforts are funded by grants from the Department of Defense and the National Institutes of Health as well as from diverse foundations and other sources. 

APG Faculty members use state-of-the art techniques and scientific rigor in research programs that thrive in combination with the strengths of the department and contribute to the overall mission of the University.

Research interests within the department include neurotrauma and neurodegenerative diseases with consideration of cardiovascular factors, the role of the immune system response to trauma and stress, and chronic pain. The department has outstanding expertise for genetic sequencing and analysis of genetic susceptibility including bioinformatics applicable to genetic and genomic approaches to understanding injury and disease. 

The department encourages research programs that integrate mechanistic studies with translational approaches to understand pathophysiology and identify therapeutic targets and potential treatments for protection, repair and recovery. 

 APG faculty members are highly collaborative with investigators in other departments at USU and externally with federal, academic and commercial partners. 

MORE FROM CMPH

FACULTY LABS

APG is home to many different labs which help advance our research, education, and public service missions. Faculty members and students collaborate on projects that push incredible boundaries. Their work is shaping military medicine and world health in many positive, powerful ways.

Dr. Agoston: Neurobiology of Traumatic Brain Injury

Dr. Anders: Non-Pharmaceutical Therapies for Pain Management

Dr. Armstrong: Translational Therapeutics Based On Mechanisms Of Pathophysiology And Regeneration In Traumatic Brain Injury And Multiple Sclerosis

Dr. Biswas: Anti-Inflammatory Therapeutics

Dr. Braga: Regulation of Neuronal Excitability in the Amygdala

Dr. Burnett: Molecular Mechanisms and Causes Underlying Neurodegenerative Disease

Dr. Byrnes: Therapeutic Strategies for Neurotrauma

Dr. Dalgard: Population Genomics

Dr. Doughty: Molecular Mechanisms Responsible for Neuronal Development and Pathology

Dr. Flagg: Molecular Cardiology

Dr. Galdzicki: Neuronal and Vascular Deficits Following Chronic Adaptation to High Altitude

Dr. Juliano: Models of TBI and Brain Infection

Dr. McCabe: Brain Injury

Dr. Mueller: Molecular Basis for Aging and Radiation Injury

Dr. Namboodiri: Intranasal Delivery of Obidoxime as a Countermeasure Against CNS Damage Caused by Nerve Agent Poisoning.

Dr. Pollard

Dr. Rothwell: Improved Hemostatic Dressings

Dr. Smyth: Calcium Signaling Pathophysiology

Dr. Srivastava: Tumor Suppressors, Genomics, and Proteomics

Dr. Zhang: Endocannabinoid Signaling in Neurological Diseases